Douglas Tsao Analyst PerformanceSenior Analyst at HC WainwrightDouglas Tsao is a stock analyst at HC Wainwright in the medical sector, covering 43 publicly traded companies. Over the past year, Douglas Tsao has issued 70 stock ratings, including buy and hold recommendations. While full access to Douglas Tsao's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Douglas Tsao's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings202 Last 10 YearsBuy Recommendations85.57% 172 Buy RatingsCompanies Covered43 Unique Companies Ratings Distribution201RatingsDistribution of strong buy, buy, hold, and sell ratings by Douglas Tsao.RatingPercentageCount Strong Buy0.0%0 ratings Buy85.6%172 ratings Hold12.9%26 ratings Sell1.5%3 ratingsOut of 201 total stock ratings issued by Douglas Tsao at HC Wainwright, the majority (85.6%) have been Buy recommendations, followed by 12.9% Hold and 1.5% Sell.Best & Worst CallsBest Call0000.0%CABAMay 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%BHCJul 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ79.1% of companies on NASDAQ34 companiesNYSE18.6% of companies on NYSE8 companiesNYSEAMERICAN2.3% of companies on NYSEAMERICAN1 companyDouglas Tsao, an analyst at HC Wainwright, currently covers 43 companies listed on NASDAQ, NYSE and NYSEAMERICAN, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical43 companies100.0%Douglas Tsao of HC Wainwright specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE20 companies46.5%PHARMACEUTICAL PREPARATIONS10 companies23.3%MED - DRUGS6 companies14.0%MED PRODUCTS2 companies4.7%MED - GENERIC DRG2 companies4.7%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC1 company2.3%BIOTECHNOLOGY1 company2.3%MED INSTRUMENTS1 company2.3% About Douglas TsaoMr. Tsao is a Managing Director of Equity Research at H.C. Wainwright whose research focuses on Biopharmaceuticals and Specialty Pharmaceuticals. Specific therapeutics areas include Endocrinology, Metabolic disease, Dermatology, and CNS in addition to other areas. Prior to joining H.C. Wainwright, Mr. Tsao was a senior equity research analyst at Barclays covering U.S. Specialty Pharmaceutical companies as well as small and midcap medical device companies. Mr. Tsao is recognized for his expertise in biosimilars and is a frequent speaker on this topic at industry conferences. Prior to Barclays Mr. Tsao worked at Lehman Brothers and his combined experience spans over ten years at these two firms. Mr. Tsao served as a Special Assistant to U.S. EPA Administrator Carol Browner from 1997-1999, received an MBA/MPH from U.C. Berkeley and graduated cum laude from Middlebury College with High Honors.Follow on LinkedIn Douglas Tsao's Ratings History at HC Wainwright Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsROIVRoivant Sciences9/18/2025Boost Price Target$15.28$20.00Buy$0.0000.00% ROIPTGXProtagonist Therapeutics9/17/2025Reiterated Rating$60.57$80.00Buy$0.0000.00% ROIALKSAlkermes9/9/2025Reiterated Rating$28.45$46.00Neutral$0.0000.00% ROIRAPPRapport Therapeutics9/8/2025Boost Price Target$14.36$34.00Buy$0.0000.00% ROIIMVTImmunovant9/4/2025Reiterated Rating$16.70$35.00Buy$0.0000.00% ROIRZLTRezolute9/3/2025Reiterated Rating$7.17$14.00Buy$0.0000.00% ROIOTLKOncobiologics8/29/2025Reiterated Rating$1.09Neutral$0.0000.00% ROIEVOEvotec8/14/2025Lower Price Target$3.81$7.00Buy$0.0000.00% ROIBHVNBiohaven8/12/2025Reiterated Rating$13.42$30.00Buy$0.0000.00% ROIEOLSEvolus8/6/2025Lower Price Target$8.91$20.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. RAPPRapport Therapeutics8/6/2025Initiated Coverage$14.43$31.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines8/5/2025Reiterated Rating$51.09$115.00Buy$0.0000.00% ROIARGXargenex8/1/2025Boost Price Target$670.33$774.00Buy$0.0000.00% ROIALKSAlkermes7/21/2025Reiterated Rating$26.37$46.00Neutral$0.0000.00% ROIPRAXPraxis Precision Medicines7/18/2025Reiterated Rating$54.94$105.00Buy$0.0000.00% ROIIRONDisc Medicine7/3/2025Reiterated Rating$53.17$118.00Buy$0.0000.00% ROIARGXargenex7/1/2025Reiterated Rating$551.22$720.00Buy$0.0000.00% ROICRNXCrinetics Pharmaceuticals6/27/2025Reiterated Rating$29.99$81.00Buy$0.0000.00% ROIROIVRoivant Sciences6/18/2025Reiterated Rating$11.11$18.00Buy$0.0000.00% ROIIRONDisc Medicine6/17/2025Reiterated Rating$52.02$118.00Buy$0.0000.00% ROISAGESage Therapeutics6/17/2025Reiterated Rating$9.07$12.00Neutral$0.0000.00% ROICABACabaletta Bio6/11/2025Reiterated Rating$1.75$25.00Buy$0.0000.00% ROIARGXargenex6/10/2025Reiterated Rating$583.62$720.00Buy$0.0000.00% ROIPTGXProtagonist Therapeutics6/3/2025Reiterated Rating$50.15$80.00Buy$0.0000.00% ROIROIVRoivant Sciences5/28/2025Reiterated Rating$10.76$18.00Buy$0.0000.00% ROIPTGXProtagonist Therapeutics5/19/2025Reiterated Rating$44.49$80.00Buy$0.0000.00% ROIXENEXenon Pharmaceuticals5/13/2025Reiterated Rating$35.85$53.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines5/1/2025Reiterated Rating$37.64$105.00Buy$0.0000.00% ROICHRSCoherus Oncology4/29/2025Reiterated Rating$1.03$7.00Buy$0.0000.00% ROIRZLTRezolute4/28/2025Reiterated Rating$3.68$14.00Buy$0.0000.00% ROIVRDNViridian Therapeutics4/23/2025Reiterated Rating$13.76$34.00Buy$0.0000.00% ROIROIVRoivant Sciences4/21/2025Reiterated Rating$10.22$18.00Buy$0.0000.00% ROIEOLSEvolus4/10/2025Reiterated Rating$10.37$27.00Buy$0.0000.00% ROIPTGXProtagonist Therapeutics4/10/2025Reiterated Rating$40.42$80.00Buy$0.0000.00% ROIARGXargenex4/8/2025Reiterated Rating$548.93$720.00Buy$0.0000.00% ROICABACabaletta Bio4/1/2025Reiterated Rating$1.39$25.00Buy$0.0000.00% ROIDAREDare Bioscience4/1/2025Reiterated Rating$2.89$12.00Buy$0.0000.00% ROISCPHscPharmaceuticals3/20/2025Reiterated Rating$3.04$18.00Buy$0.0000.00% ROIIMVTImmunovant3/19/2025Reiterated Rating$18.71$51.00Buy$0.0000.00% ROICHRSCoherus Oncology3/11/2025Reiterated Rating$1.04$7.00Buy$0.0000.00% ROIPTGXProtagonist Therapeutics3/10/2025Reiterated Rating$38.35$54.00Buy$0.0000.00% ROIEOLSEvolus3/5/2025Reiterated Rating$14.35$27.00Buy$0.0000.00% ROIBHVNBiohaven3/4/2025Reiterated Rating$30.50$54.00Buy$0.0000.00% ROISCPHscPharmaceuticals3/3/2025Reiterated Rating$3.28$18.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines3/3/2025Lower Price Target$38.60$105.00Buy$0.0000.00% ROIAPLSApellis Pharmaceuticals3/3/2025Reiterated Rating$25.15$57.00Buy$0.0000.00% ROIPTGXProtagonist Therapeutics3/3/2025Reiterated Rating$39.03$54.00Buy$0.0000.00% ROIARGXargenex2/28/2025Boost Price Target$624.70$720.00Buy$0.0000.00% ROINERVMinerva Neurosciences2/26/2025Reiterated Rating$1.79$5.00Neutral$0.0000.00% ROITBPHTheravance Biopharma2/25/2025Reiterated Rating$8.86$15.00Buy$0.0000.00% ROIPTGXProtagonist Therapeutics2/24/2025Boost Price Target$38.75$54.00Buy$0.0000.00% ROIOTLKOncobiologics2/18/2025Lower Price Target$1.87$3.00Buy$0.0000.00% ROICABACabaletta Bio2/18/2025Reiterated Rating$2.34$25.00Buy$0.0000.00% ROIEOLSEvolus2/14/2025Reiterated Rating$15.04$27.00Buy$0.0000.00% ROIRZLTRezolute2/13/2025Reiterated Rating$4.79$14.00Buy$0.0000.00% ROIALKSAlkermes2/13/2025Reiterated Rating$33.50$46.00Neutral$0.0000.00% ROIAPLSApellis Pharmaceuticals2/13/2025Reiterated Rating$28.51$57.00Buy$0.0000.00% ROISAGESage Therapeutics2/12/2025Reiterated Rating$7.19$12.00Neutral$0.0000.00% ROIROIVRoivant Sciences2/11/2025Reiterated Rating$10.55$18.00Buy$0.0000.00% ROIIMVTImmunovant2/7/2025Reiterated Rating$20.39$51.00Buy$0.0000.00% ROIPTGXProtagonist Therapeutics2/7/2025Reiterated Rating$37.75$50.00Buy$0.0000.00% ROIRZLTRezolute2/5/2025Reiterated Rating$5.50$14.00Buy$0.0000.00% ROICHRSCoherus Oncology1/23/2025Reiterated Rating$1.31$7.00Buy$0.0000.00% ROIEOLSEvolus1/22/2025Reiterated Rating$13.48$27.00Buy$0.0000.00% ROIIRONDisc Medicine1/21/2025Reiterated Rating$61.41$118.00Buy$0.0000.00% ROICABACabaletta Bio1/17/2025Reiterated Rating$2.43$25.00Buy$0.0000.00% ROIOTLKOncobiologics1/17/2025Reiterated Rating$2.19$30.00Buy$0.0000.00% ROIARGXargenex1/14/2025Reiterated Rating$671.62$717.00Buy$0.0000.00% ROIAPLSApellis Pharmaceuticals1/14/2025Reiterated Rating$28.59$57.00Buy$0.0000.00% ROICRNXCrinetics Pharmaceuticals1/13/2025Reiterated Rating$40.59$81.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.